A Meeting Place for Patients, Caregivers and Patient Associations
General information
This section provides information for patients, users, caregivers, patient groups and associations as drug and technological products are being evaluated. You'll find:
If you have any questions about the consultation process for drugs evaluated for listing, please contact our team at the following e-mail address: plan.commentaires.inscription@inesss.qc.ca.